Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors
Clinical trial NCT04517539 · UNKNOWN
Trial details
- NCT number
- NCT04517539
- Sponsor
- Shanghai Cancer Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2022-12-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.